{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:45:43Z","timestamp":1779911143182,"version":"3.53.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.eururo.2007.04.026","type":"journal-article","created":{"date-parts":[[2007,4,20]],"date-time":"2007-04-20T16:07:33Z","timestamp":1177085253000},"page":"850-859","source":"Crossref","is-referenced-by-count":87,"title":["Botulinum Toxin A Improves the Quality of Life of Patients with Neurogenic Urinary Incontinence"],"prefix":"10.1016","volume":"52","author":[{"given":"Brigitte","family":"Schurch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Denys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris M.","family":"Kozma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat Ray","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terra","family":"Slaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2007.04.026_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1191\/1352458504ms1060oa","article-title":"Bladder and sexual function among women with multiple sclerosis","volume":"10","author":"Borello-France","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.eururo.2007.04.026_bib2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/00002060-200112000-00008","article-title":"Bladder management and quality of life after spinal cord injury","volume":"80","author":"Hicken","year":"2001","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.eururo.2007.04.026_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1185\/030079906X89702","article-title":"Improving the global management of the neurogenic bladder patient. Part I. The complexity of patients","volume":"22","author":"Denys","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.eururo.2007.04.026_bib4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.04.026_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1023\/A:1008974420049","article-title":"A health related quality of life measure for use in patients with urge urinary incontinence: a validation study","volume":"8","author":"Lubeck","year":"1999","journal-title":"Qual Life Res"},{"key":"10.1016\/j.eururo.2007.04.026_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0090-4295(99)80384-7","article-title":"Quality of life of persons with urinary incontinence: development of a new measure","volume":"47","author":"Wagner","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2007.04.026_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0302-2838(03)00097-6","article-title":"Impact of urinary incontinence and overactive bladder on quality of life","volume":"43","author":"Chiaffarino","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.04.026_bib8","series-title":"The I-QOL: A quality of life instrument specific to persons with urinary incontinence: user\u2019s manual and scoring diskette for United States version","author":"Patrick","year":"1999"},{"key":"10.1016\/j.eururo.2007.04.026_bib9","unstructured":"Schurch B, Denys P, Kozma CM, Reese PR, Slaton T, Barron R. The reliability, validity and impact of the use of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence: validation of the measure and evaluation of the impact of botulinum toxin type A (BoNTA) treatment. Arch Phys Med Rehabil. In press."},{"key":"10.1016\/j.eururo.2007.04.026_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/00365590410015867","article-title":"Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions","volume":"38","author":"Bagi","year":"2004","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2007.04.026_bib11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.04.026_bib12","first-page":"2543","article-title":"Efficacy of botulinum-A toxin in adults with neurogenic overactive bladder: initial results","volume":"12","author":"Hajebrahimi","year":"2005","journal-title":"Can J Urol"},{"key":"10.1016\/j.eururo.2007.04.026_bib13","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1053\/j.gastro.2003.10.059","article-title":"Symptom severity and QOL scales for urinary incontinence","volume":"126","author":"Naughton","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.eururo.2007.04.026_bib14","first-page":"889","article-title":"Measuring disease-specific quality of life in clinical trials","volume":"134","author":"Guyatt","year":"1986","journal-title":"CMAJ"},{"key":"10.1016\/j.eururo.2007.04.026_bib15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eururo.2005.12.012","article-title":"Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes","volume":"49","author":"Kalsi","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.04.026_bib16","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/01.ju.0000143889.00681.3f","article-title":"The effect of botulinum-A toxin on patients with severe urge urinary incontinence","volume":"172","author":"Flynn","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.04.026_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1464-410X.2006.06192.x","article-title":"Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury","volume":"98","author":"Patki","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2007.04.026_bib18","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.ju.0000177477.83991.88","article-title":"Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial","volume":"174","author":"Ghei","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.04.026_bib19","doi-asserted-by":"crossref","unstructured":"Hay-Smith J, Herbison P, Ellis G, Morris A. Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev 2005:CD005429.","DOI":"10.1002\/14651858.CD005429"},{"key":"10.1016\/j.eururo.2007.04.026_bib20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.326.7394.841","article-title":"Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review","volume":"326","author":"Herbison","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2007.04.026_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1464-410X.2004.05255.x","article-title":"Improved quality of life in patients with overactive bladder symptoms treated with solifenacin","volume":"95","author":"Kelleher","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2007.04.026_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1021372426421","article-title":"Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study","volume":"34","author":"Diokno","year":"2002","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.eururo.2007.04.026_bib23","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s11136-005-5266-5","article-title":"Quality of life of women with urinary incontinence: cross-cultural performance of 15 language versions of the I-QOL","volume":"14","author":"Bushnell","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1016\/j.eururo.2007.04.026_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0090-4295(98)00454-3","article-title":"Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL)","volume":"53","author":"Patrick","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2007.04.026_bib25","first-page":"2007","article-title":"Qualitative assessment of content validity of the incontinence quality of life questionnaire (I-QOL) in neurogenic patients (spinal cord injury and MS)","volume":"14","author":"Lee","year":"2005","journal-title":"Qual Life Res"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283807005568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283807005568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T03:24:22Z","timestamp":1546917862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283807005568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0302283807005568"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2007.04.026","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}